DealForge autonomously sources, scores, and writes investment memos on venture deals. Stop manually hunting.
1,180+ deals tracked · 22 AI investment memos · Updated daily
Built a $29 SaaS that interprets a $300 clinical gut lab PDFs nobody else accepts (testtotable.com)
I kept seeing people in r/Longcovidgutdysbiosis and r/GutHealth talk about uploading their gut lab reports into ChatGPT and ask "what does this mean?" These are $300+ clinical tests, and patients are getting back a confusing PDF report with no interpretation. Their doc says "eat more fiber." Lol. So I built Test to Table, which reads the report, extracts the markers, deletes the report, and outputs a 6-week phased food protocol with exact quantities per flagged marker. There are 13 competitors in the microbiome interpretation space, but only 2 accept outside uploads...and those 2 only handle 16S DNA tests. Nobody handles the high-volume clinical reports like GI-MAP, Genova, and Biomesight. It might be low, but I thought an introductory $29 for the first 200 customers, then $49 after, would be enticing. Anyone who uploads a report sees flagged markers and the reasons (to sanity-check marker extraction) and gets the first two weeks of the protocol for free; all before paying and without requiring authentication or subscription. Any and all feedback welcome. Bring the good, bad, or ugly. [testtotable.com](http://testtotable.com)
Test to Table identifies a sharp, high-intent pain point in the microbiome market by providing the 'last mile' of utility for expensive clinical tests. However, the venture faces significant regulatory hurdles regarding medical advice liability and lacks a clear technical moat or disclosed clinical expertise to scale safely.